VBI Vaccines Was Notified That Its Common Shares Will Be Delisted From Nasdaq Effective As Of Opening Of Business On August 8, 2024; Does Not Intend To Appeal The Delisting Determination
Author: Benzinga Newsdesk | August 02, 2024 04:08pm
On July 30, 2024, the Company received a letter from the listing qualifications department staff of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that its common shares will be delisted from Nasdaq effective as of opening of business on August 8, 2024. The Company does not intend to appeal the delisting determination.
Posted In: VBIV